265 related articles for article (PubMed ID: 26059417)
21. MicroRNA-497 targets hepatoma-derived growth factor and suppresses human prostate cancer cell motility.
Wu D; Niu X; Pan H; Zhang Z; Zhou Y; Qu P; Zhou J
Mol Med Rep; 2016 Mar; 13(3):2287-92. PubMed ID: 26780929
[TBL] [Abstract][Full Text] [Related]
22. Actin-related protein 2/3 complex subunit 5 (ARPC5) contributes to cell migration and invasion and is directly regulated by tumor-suppressive microRNA-133a in head and neck squamous cell carcinoma.
Kinoshita T; Nohata N; Watanabe-Takano H; Yoshino H; Hidaka H; Fujimura L; Fuse M; Yamasaki T; Enokida H; Nakagawa M; Hanazawa T; Okamoto Y; Seki N
Int J Oncol; 2012 Jun; 40(6):1770-8. PubMed ID: 22378351
[TBL] [Abstract][Full Text] [Related]
23. Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma.
Yoshino H; Enokida H; Itesako T; Tatarano S; Kinoshita T; Fuse M; Kojima S; Nakagawa M; Seki N
J Hum Genet; 2013 Aug; 58(8):508-16. PubMed ID: 23635949
[TBL] [Abstract][Full Text] [Related]
24. Regulation of E3 ubiquitin ligase-1 (WWP1) by microRNA-452 inhibits cancer cell migration and invasion in prostate cancer.
Goto Y; Kojima S; Kurozumi A; Kato M; Okato A; Matsushita R; Ichikawa T; Seki N
Br J Cancer; 2016 May; 114(10):1135-44. PubMed ID: 27070713
[TBL] [Abstract][Full Text] [Related]
25. microRNA-330 inhibits cell motility by downregulating Sp1 in prostate cancer cells.
Mao Y; Chen H; Lin Y; Xu X; Hu Z; Zhu Y; Wu J; Xu X; Zheng X; Xie L
Oncol Rep; 2013 Jul; 30(1):327-33. PubMed ID: 23670210
[TBL] [Abstract][Full Text] [Related]
26. Tumor-suppressive microRNA-29 family inhibits cancer cell migration and invasion directly targeting LOXL2 in lung squamous cell carcinoma.
Mizuno K; Seki N; Mataki H; Matsushita R; Kamikawaji K; Kumamoto T; Takagi K; Goto Y; Nishikawa R; Kato M; Enokida H; Nakagawa M; Inoue H
Int J Oncol; 2016 Feb; 48(2):450-60. PubMed ID: 26676674
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-146b acts as a potential tumor suppressor in human prostate cancer.
Ding HY; Qian WQ; Xu J
J BUON; 2016; 21(2):434-43. PubMed ID: 27273955
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-103 suppresses tumor cell proliferation by targeting PDCD10 in prostate cancer.
Fu X; Zhang W; Su Y; Lu L; Wang D; Wang H
Prostate; 2016 May; 76(6):543-51. PubMed ID: 26771762
[TBL] [Abstract][Full Text] [Related]
29. The tumor-suppressive microRNA-143/145 cluster inhibits cell migration and invasion by targeting GOLM1 in prostate cancer.
Kojima S; Enokida H; Yoshino H; Itesako T; Chiyomaru T; Kinoshita T; Fuse M; Nishikawa R; Goto Y; Naya Y; Nakagawa M; Seki N
J Hum Genet; 2014 Feb; 59(2):78-87. PubMed ID: 24284362
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-940 suppresses prostate cancer migration and invasion by regulating MIEN1.
Rajendiran S; Parwani AV; Hare RJ; Dasgupta S; Roby RK; Vishwanatha JK
Mol Cancer; 2014 Nov; 13():250. PubMed ID: 25406943
[TBL] [Abstract][Full Text] [Related]
31. The tumor-suppressive microRNA-1/133a cluster targets PDE7A and inhibits cancer cell migration and invasion in endometrial cancer.
Yamamoto N; Nishikawa R; Chiyomaru T; Goto Y; Fukumoto I; Usui H; Mitsuhashi A; Enokida H; Nakagawa M; Shozu M; Seki N
Int J Oncol; 2015 Jul; 47(1):325-34. PubMed ID: 25955017
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA PCAT-1 contributes to tumorigenesis by regulating FSCN1 via miR-145-5p in prostate cancer.
Xu W; Chang J; Du X; Hou J
Biomed Pharmacother; 2017 Nov; 95():1112-1118. PubMed ID: 28922730
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of cortactin and SIRT1 expression attenuates migration and invasion of prostate cancer DU145 cells.
Nakane K; Fujita Y; Terazawa R; Atsumi Y; Kato T; Nozawa Y; Deguchi T; Ito M
Int J Urol; 2012 Jan; 19(1):71-9. PubMed ID: 22050448
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-218 inhibits tumor growth and increases chemosensitivity to CDDP treatment by targeting BCAT1 in prostate cancer.
Zhu W; Shao Y; Peng Y
Mol Carcinog; 2017 Jun; 56(6):1570-1577. PubMed ID: 28052414
[TBL] [Abstract][Full Text] [Related]
35. Enhanced expression of centromere protein F predicts clinical progression and prognosis in patients with prostate cancer.
Zhuo YJ; Xi M; Wan YP; Hua W; Liu YL; Wan S; Zhou YL; Luo HW; Wu SL; Zhong WD; Wu CL
Int J Mol Med; 2015 Apr; 35(4):966-72. PubMed ID: 25647485
[TBL] [Abstract][Full Text] [Related]
36. Silencing of microRNA-3175 represses cell proliferation and invasion in prostate cancer by targeting the potential tumor-suppressor SCN4B.
Huang H; Qing XY; Zhou Q; Li HD; Hu ZY
Kaohsiung J Med Sci; 2021 Jan; 37(1):20-26. PubMed ID: 32833340
[TBL] [Abstract][Full Text] [Related]
37. Tumor suppressive microRNA-1 mediated novel apoptosis pathways through direct inhibition of splicing factor serine/arginine-rich 9 (SRSF9/SRp30c) in bladder cancer.
Yoshino H; Enokida H; Chiyomaru T; Tatarano S; Hidaka H; Yamasaki T; Gotannda T; Tachiwada T; Nohata N; Yamane T; Seki N; Nakagawa M
Biochem Biophys Res Commun; 2012 Jan; 417(1):588-93. PubMed ID: 22178073
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-613 represses prostate cancer cell proliferation and invasion through targeting Frizzled7.
Ren W; Li C; Duan W; Du S; Yang F; Zhou J; Xing J
Biochem Biophys Res Commun; 2016 Jan; 469(3):633-8. PubMed ID: 26703210
[TBL] [Abstract][Full Text] [Related]
39. miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells.
Dynoodt P; Speeckaert R; De Wever O; Chevolet I; Brochez L; Lambert J; Van Gele M
Int J Oncol; 2013 Apr; 42(4):1443-51. PubMed ID: 23404256
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis.
Chen QY; Jiao DM; Yan L; Wu YQ; Hu HZ; Song J; Yan J; Wu LJ; Xu LQ; Shi JG
Mol Biosyst; 2015 Aug; 11(8):2290-302. PubMed ID: 26075299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
